stockrow
Friday 6 November 2026
Export ATEC’s income statement to Excel — free account
Alphatec Holdings, Inc.
ATEC Healthcare Medical Devices
Alphatec Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $764.2 million, up 25.0% from fiscal 2024.
- Revenue
- +12.6%
- EPS
- +81.7%
- Free cash flow
- −149.2%
- Total debt
- −2.27%
Quarter to September 2026, against a year earlier
7.45
0.35
−4.49%
Follow ATEC
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
1.93 | 1.66 | 2.13 | 4.13 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
86.13 | 66.03 | 1,298.28 | 152.66 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 254.09 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
2.49 | 2.22 | 2.68 | 4.66 | |
EV/EBITDA |
25.46 | 29.31 | 43.67 | 155.25 | |
EV/Operating CF |
34.09 | 32.04 | 40.89 | 78.76 | |
EV/FCF |
(200.34) | (315.56) | (2,696.39) | (807.82) | |
Quick Ratio |
1.06 | 0.96 | 1.03 | 1.18 | |
Current Ratio |
2.36 | 1.89 | 1.90 | 2.06 | |
Net Debt/EBITDA |
14.82 | 14.28 | 79.25 | 21.84 | |
Debt/Assets |
68.65% | 64.57% | 63.53% | 71.53% | |
Debt/Equity |
(237.62) | (42.32) | (94.99) | 45.54 | |
Asset Turnover |
1.06 | 1.03 | 0.99 | 0.98 | |
Operating CF/Net income |
(3.45) | (0.80) | (0.04) | (0.95) | |
Capex/Depreciation |
(0.72) | (0.75) | (0.53) | (0.55) | |
Interest Coverage |
0.31 | (0.17) | (1.93) | (0.68) | |
Research and Development Expense of Revenue |
8.14% | 8.51% | 9.14% | 10.68% | |
Selling, General and Administrative Expense of Revenue |
59.91% | 62.76% | 71.34% | 60.44% | |
Intangible Assets out of Total Assets |
0.21 | 0.21 | 0.21 | 0.21 | |
Share Based Compensation of Revenue |
6.31% | 8.50% | 12.32% | 9.11% | |
Graham Net Nets |
(0.23) | (0.26) | (0.21) | (0.10) | |
Graham Number |
0.43 | 1.11 | 0.80 | 0.00 | |
Earnings Yield |
(5.38%) | (8.21%) | (7.54%) | (4.52%) | |
Free Cash Flow Yield |
(0.64%) | (0.42%) | (0.05%) | (0.14%) | |
Revenue per Share |
1.41 | 1.36 | 1.25 | 1.42 | |
Operating CF per Share |
0.12 | 0.13 | 0.01 | 0.14 | |
Capex per Share |
(0.13) | (0.14) | (0.09) | (0.10) | |
Free Cash Flow per Share |
(0.01) | (0.01) | (0.08) | 0.04 | |
Cash per Share |
0.51 | 0.76 | 0.91 | 1.07 | |
Shareholders Equity per Share |
(0.01) | (0.08) | (0.03) | 0.08 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.01) | (0.08) | (0.03) | 0.08 | |
Free Cash Flow |
(1.55) | (1.58) | (13.02) | 5.72 | |
Working Capital |
246.40 | 211.05 | 215.92 | 231.70 | |
Capital Expenditures |
(20.41) | (22.09) | (14.31) | (14.96) | |
Net Current Asset Value |
(371.88) | (354.08) | (348.66) | (327.91) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.09 | 0.10 | 0.07 | 0.07 | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
103.82 | 103.02 | 97.93 | 90.15 | |
Average Payables |
49.25 | 54.67 | 42.40 | 46.94 | |
Average Inventory |
186.88 | 182.32 | 178.45 | 172.35 | |
Average Assets |
792.00 | 790.66 | 792.48 | 783.46 | |
Average Common Equity |
4.60 | 5.85 | (45.64) | (0.87) |
Columns are period end dates · fundamentals updated 6 Nov 2026